EMEA-002087-PIP01-16-M01
Key facts
| Active substance |
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0369/2022
|
| PIP number |
EMEA-002087-PIP01-16-M01
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of acute graft versus host disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Xenikos BV
Tel. +31 243000100 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|